Kasir Collaj
19 statements · 1 topic
Featured statements
One of the biggest challenges for babies with CDH is that fetal hypoplastic lungs are immature, whereby there is an impairment of cell differentiation, especially in the epithelium.
quote ·
Congenital Diaphragmatic Hernia
Congenital diaphragmatic hernia is characterized by impaired fetal lung growth and maturation. This condition has unacceptably high mortality and morbidity rates.
quote ·
Congenital Diaphragmatic Hernia
Nothing matches these filters — clear the search or widen the filters.
Kasir's statements about Congenital Diaphragmatic Hernia 19 statements
Open the Congenital Diaphragmatic Hernia collection →
Best of the Best in Pediatric Surgery Winner Announcement
Quotation
Congenital diaphragmatic hernia is characterized by impaired fetal lung growth and maturation. This condition has unacceptably high mortality and morbidity rates.
Open
Statement
Congenital diaphragmatic hernia is characterized by impaired fetal lung growth and maturation
Open
Quotation
One of the biggest challenges for babies with CDH is that fetal hypoplastic lungs are immature, whereby there is an impairment of cell differentiation, especially in the epithelium.
Open
Statement
One of the biggest challenges for babies with CDH is that fetal hypoplastic lungs are immature with impairment of cell differentiation, especially in the epithelium
Open
Statement
Amniotic fluid stem cell derived EVs can rescue fetal lung growth and maturation in several models of CDH at the pseudoglandular stage
Open
Statement
The canalicular and saccular stages are translationally relevant developmental stages where intervention is possible for CDH
Open
Statement
The nitrophin model is a well-established model for studying CDH, created by administering the herbicide nitrophin to pregnant rat dams at embryonic day 9.5
Open
Statement
Hypoplastic lungs at canalicular and saccular stages show down-regulation of alveolar type 1 and 2 cells, as well as basal and club cells compared to control
Open
Quotation
Remarkably, when we treat these hypoplastic lungs with the amniotic fluid stem cell derived extracellular vesicles, we are able to restore these primary markers, as you can see in the green shaded area, thus indicating that cell homeostasis can be achieved.
Open
Statement
Treatment of hypoplastic lungs with amniotic fluid stem cell derived extracellular vesicles restores primary markers of alveolar type 1 and 2 cells, basal cells, and club cells, indicating cell homeostasis can be achieved
Open
Statement
In vivo experiments have been performed looking at different administration routes including intraamniotic and tracheal routes for extracellular vesicles
Open
Statement
Collaboration with Dr. Jan De Prest is underway to look at safety and feasibility of AFSC-EV treatment in a lab model
Open
Statement
The lack of ciliated cell rescue may be due to an imbalance of different cell types in the hypoplastic fetal lung, with the treatment achieving overall cell homeostatic balance rather than rescuing every specific cell type
Open
Statement
Key markers expressed in branching morphogenesis are being rescued effectively with AFSC-EV treatment
Open